ELENA BELOVA: Open Payments
NPI 1548945793 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 12 payments from 7 companies in 2025. Trend: 2023 $258 · 2024 $17 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $148 |
| Regeneron Healthcare Solutions, Inc. | 3 | $112 |
| Incyte Corporation | 2 | $51 |
| UCB, Inc. | 2 | $44 |
| Organogenesis Inc. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $23 |
| Almatica Pharma LLC | 1 | $17 |
Products named: DUPIXENT, OPZELURA, Bimzelx, VIA MATRIX, TREMFYA, LOREEV XR.
Industry payments across FL — which companies pay providers there.
